This trend in PSA lowering among metformin users does not always seem to be of significance [60,61]. Promising results exist from animal studies, as metformin administration to mice with xenografts of human PCa cells contributed to the reduction of tumor growth by 35% to 50%, which was attributed to the fall in cyclin D1 activity [52]. This evidence concerns the gene CCND1 and posterior cortical atrophy.